Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
June 26, 2026
The D.C. Circuit on Friday backed the U.S. Food and Drug Administration's lower court win in Norwich Pharmaceuticals' challenge to the agency's refusal to approve an application to bring a generic version of a prescription antibiotic for irritable bowel syndrome to market until 2029.
-
June 26, 2026
European enforcers are investigating whether Sanofi used a messaging campaign directed mainly at healthcare professionals in Germany and France to disparage the only rival flu vaccine recommended for vulnerable patients.
-
June 26, 2026
The U.S. Drug Enforcement Administration will kick off three weeks of hearings Monday on a proposal to move marijuana from Schedule I to Schedule III under the Controlled Substances Act, by presenting testimony asserting that the drug has a valid, currently accepted medical use.
-
June 26, 2026
With U.S. District Judge Christopher Wolfe set to take over much of Judge Alan Albright's patent infringement docket in the Western District of Texas later this year, attorneys should prepare for potential differences in Judge Wolfe's approach to the court's high volume of patent litigation, say attorneys at Sidley Austin.
-
June 26, 2026
The U.S. International Trade Commission found Friday certain monomers and oligomers imported from South Korea that were determined to be selling at less than fair value are harming domestic producers, teeing up duties to be ordered on those goods.
See more Life Sciences news